Skip to main content

Animations

MJFF Publications

4331 - 4340 of 8818 Results
Title
Year
  • Year
  • 2024
  • 2023
  • 2024
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Clinical prediction of GBA carrier status in Parkinson’s disease
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100251
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Association of liver fibrosis with cognitive decline in Parkinson’s disease
    Journal Name: Journal of Clinical Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jocn.2023.11.019
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.jagp.2023.12.024
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Different impulse control disorder evolution patterns and white matter microstructural damage in the progression of Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2023.1260630
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complex
    Journal Name: Experimental Biology and Medicine
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/15353702231209411
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Altered dynamic functional network connectivity in drug-naïve Parkinson’s disease patients with excessive daytime sleepiness
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2023.1282962
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Gut mucosal cells transfer α-synuclein to the vagus nerve
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.172192
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcad346
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)
    Journal Name: IBRO Neuroscience Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ibneur.2023.10.001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson’s disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2023.113544
    Citation Count: 18
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.